Sign in

CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company

Neumora Therapeutics, Inc.

Sign in to watch
Ticker
NMRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
844367680
Phone
(857) 760-0900
Business address
260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$481,506
in 2 filings

Net −$481,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Aurora Daljit Singh −$482K See Remarks sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2025-02-13 Halawa Alaa Director Grant or award · Stock Option (Right to Buy) +46,455 46,455
2025-02-13 Halawa Alaa Director Grant or award · Stock Option (Right to Buy) +28,571 28,571
2025-02-13 Burow Kristina Director Returned to the company · Stock Option (Right to Buy) −46,455 0
2025-02-13 Burow Kristina Director Returned to the company · Stock Option (Right to Buy) −28,571 0
2025-02-13 Burow Kristina Director Grant or award · Stock Option (Right to Buy) +46,455 46,455
2025-02-13 Burow Kristina Director Grant or award · Stock Option (Right to Buy) +28,571 28,571
2025-02-13 Duncan Jason See Remarks Grant or award · Stock Option (Right to Buy) +500,000 500,000
2025-02-13 Duncan Jason See Remarks Returned to the company · Stock Option (Right to Buy) −400,000 0
2025-02-13 Duncan Jason See Remarks Grant or award · Stock Option (Right to Buy) +400,000 400,000
2024-12-27 BERNS PAUL L Director Gift −133,097 7,685,069
2024-12-27 BERNS PAUL L Director Gift −133,097 7,551,972
2024-12-27 BERNS PAUL L Director Gift −133,097 7,418,875
2024-10-18 Fust Matthew K Director Option exercise 10b5-1 +6,205 $8.79 $55K 26,305
2024-10-18 Fust Matthew K Director Option exercise 10b5-1 +7,844 $2.52 $20K 34,149
2024-10-18 Fust Matthew K Director Sale 10b5-1 −14,049 $17.03 $239K 20,100
2024-10-18 Fust Matthew K Director Option exercise · Stock Option (Right to Buy) 10b5-1 −6,205 0
2024-10-18 Fust Matthew K Director Option exercise · Stock Option (Right to Buy) 10b5-1 −7,844 85,586
2024-10-17 Fust Matthew K Director Option exercise 10b5-1 +3,783 $8.32 $31K 23,883
2024-10-17 Fust Matthew K Director Option exercise 10b5-1 +1,800 $8.79 $16K 25,683
2024-10-17 Fust Matthew K Director Option exercise 10b5-1 +2,156 $2.52 $5K 27,839

Page 12 of 20 · 384 trades